T. A. Darwish et al.
material was purified on a silica column (eluent: dichloromethane/MeOH) and 5.32 (0.407 H, br s, CH = CD). 2H NMR (61.4 MHz, CDCl3): δD 0.81
to give a pale yellow oil (25.0 g, 83% yield). 1H NMR (400 MHz, CDCl3): δH (3.5D, br s, CD3), 1.21 (23.8D, br s, 10 × CD2), 1.55 (1.64D, br s, CD2), 1.94
1.17 (0.108 H, br s, residual 4 × CH2), 1.56 (0.094 H, br s, residual 2 × CH2), (3.8D, br s, 2 × CD2-C = C), 2.25 (1.2D, br s, CD2COO,) 5.36 (1.6D, br s, CH =CD).
2.20 (0.093 H, br s, residual CH2), 3.62 (3.000 H, s, CH3), 3.69 (2.013 H, d, JH- (Figures 2 and S25 in the Supplementary data).
P = 12.9 Hz, CH2-P), 7.70–7.81 (15.897 H, m, PPh3). 2H NMR (61.4 MHz,
The aforementioned methyl ester (3.6 g, 10 mmol) was dissolved in
CDCl3): δD 1.10–1.52 (12.0D, br m, 6 × CD2), 2.19 (2.1D, br m, CD2). 13C N2-purged MeOH (250 mL). Lithium hydroxide monohydrate (3.95 g,
{1H} NMR (100.6 MHz, CDCl3,): δC 22.5 (d, JC-P = 50 Hz, CH2-P), 27.0–28.0 94 mmol) dissolved in N2-purged water (100 mL) was added to the methyl
(m, all CD2), 51.4 (s, CH3), 118.4 (d, JC-P = 85.6 Hz, Ph), 130.5 (d, JC- ester solution with stirring. Initially, the reaction mixture was cloudy but
P = 12.3 Hz, Ph), 133.7 (d, JC-P = 9.98 Hz, Ph), δ 135.0 (d, JC-P = 3 Hz, Ph), δ eventually the solution became clear. The hydrolysis reaction was
174.4 (s, CO). (Supplementary data, Figures S18–S20).
monitored by TLC by using protonated oleic acid as reference. The
reaction reached completion after 24 h. HCl (1 M) was added to the
reaction mixture to acidify it to pH 1, where the solution became turbid
again indicating the liberation of the free acid. The turbid aqueous
solution was extracted three times with diethyl ether. The organic phase
was washed once with brine and then dried over anhydrous Na2SO4.
The solvent was evaporated under reduced pressure to give pale yellow
oil. The oil was purified on a silica column [eluant DCM : EtOAc (10:4)] to
give a colourless oil of deuterated oleic acid (10) (2.5 g, 80% yield). 1H
NMR (400 MHz, CDCl3): δH 0.82 (0.036 H, br s, residual CH3), 1.23 (0.279 H,
br m , residual 10 × CH2,), 1.58 (0.029, br s, residual CH2), 1.95 (0.104 H, br
s, residual 2 × CH2-C = C), 2.32 (0.890 H, br m, residual CH2COO-), 5.25
(0.045 H, br s, residual CH = CD) and 5.32 (0.407 H, br s, CH = CD). 2H NMR
(61.4 MHz, CDCl3): δD 0.81 (4.5D, br s, CD3), 1.21 (23.8D, br s, 10 × CD2),
1.57 (1.9D, br s, CD2), 1.94 (4.5D, br s, 2 × CD2-C = C), 2.30 (1.2D, br s,
CD2COO-) 5.36 (1.4D, br s, CH = CD). 13C{1H} NMR (100.6 MHz, CDCl3): δC
12.9 (m), 21.5 (m), 23.7 (m), 26.2 (m), 28.0 (br m), 30.6 (m), 33.3 (m),
Preparation of compound 8
Anhydrous THF (ca. 220 mL) was added under
a dry and inert
atmosphere into a flask containing lithium aluminium deuteride (6.5 g,
15 mmol) cooled in an ice bath. Nonanoic acid-d17 (17.1 g, 98 mmol) in
ca. 50 mL of anhydrous THF was added slowly, and the resulting mixture
was refluxed overnight with vigorous stirring. Water (ca. 50 ml) was
added very slowly to decompose the excess lithium aluminium
deuteride, followed by addition of dilute sulfuric acid (1 M) to dissolve
the resulting precipitate. The mixture was extracted with diethyl ether,
the extract washed with NaHCO3 and dried with anhydrous MgSO4.
The solvent was removed in vacuo, and the crude material was purified
on a silica column (eluent: dichloromethane/EtOAc, 9:1) to give a
colourless oil (14.3 g, 89% yield). 1H NMR (400 MHz, CDCl3): δH 0.87 (br
s, residual CH3), 1.26 (br s, residual CH2), 1.41 (s, OH), 1.52 (br s, residual
CH2), 3.60 (br s, residual CH2-OH). 2H NMR (61.4 MHz, CDCl3): δD 0.81
(3.0D, br s, CD3), 1.20 (12.3D, br s, 6 × CD2), 1.50 (2.2D, br s, CD2), 3.59
(1.8D, br s, CD2-OH). (Supplementary data, Figures S21 and S22).
129.5 (s), 179.2 (s). ESI-MS: 5.9%, d33; 25.3%, d32; 34.8%, d31; 23.4%, d30
8.3%, d29; 2%, d28. (Figures 3–5 and Figure S26 in Supplementary data).
;
Synthesis of [D64]dioleoyl-sn-glycero-3-phosphocholine (11)
Preparation of compound 9
from deuterated oleic acid (10)
Pyridinium chlorochromate (13.8 g, 64 mmol) and celite (14 g) were
added in one portion to a stirred solution of compound 8 (7.1 g,
43.5 mmol) in dry DCM (110 mL). The suspension was stirred vigorously
under N2 atmosphere for 18 h, and then the dark mixture was filtered
through a plug of florisil. Diethyl ether (400 mL) was run through the
plug. The ether washing was evaporated under vacuum to give a pale
orange oil (7.5 g). The oil was distilled under reduced pressure (11 mbar)
and fractions boiling between 70°C and 90°C were collected to give the
aldehyde 9 as clear oil (3 g, 43% yield). 1H NMR (400 MHz, CDCl3): δH
0.82 (br s, residual CH3), 1.23 (br m, residual 5 × CH2), 1.57 (br s, residual
CH2 masked by H2O), 2.37 (br s, residual CH2). 2H NMR (61.4 MHz, CDCl3):
δD 0.81 (3.0D, br s, CD3), 1.21 (9.8D, br s, 5 × CD2), 1.56 (2.0D, br s, CD2),
2.35 (1.7D, br s, CD2), 9.79 (0.8D, br s, CDO). (Supplementary data, Figures
S23 and S24).
[D64]Dioleoyl-sn-glycero-3-phosphocholine was synthesised according to
modified literature procedure45
where the oleoyl chains are
a
,
deuterated. In a 50-mL single-necked round-bottomed flask containing
sn-glycero-phosphocholine-CdCl2 complex (60 mg, 0.136 mmol) was
added 105 mg (0.335 mmol) of 10 dissolved in 10 ml of alcohol free
chloroform (anhydrous). The resulting suspension was vigorously stirred
and 4-dimethylamino pyridine (48 mg, 0.393 mmol) was added followed
by dicyclohexylcarbodiimide (81 mg, 0.393 mmol). The contents of the
flask were then degassed with N2, stoppered, protected from light and
stirred for 4 days at room temperature. The progress of the reaction
was monitored by TLC on silica gel CHCl3-CH3OH-H2O 65:25:4. When
the reaction was complete, chloroform was added, and the mixture
was filtered through a Celite pad (product of Sigma-Aldrich), which was then
washed with 15 mL more of chloroform. The chloroform was removed under
reduced pressure at room temperature, and the residue was dissolved in 5 mL
of CHCl3/CH3OH 1:1 and passed through a silica column, which was
preconditioned with CHCl3. The fractions containing phospholipids were
Preparation of compound 10
Phosphonium salt 6 (9.6 g, 18.3 mmol) was dissolved in dry 1,3-Dimethyl- combined, and the solvent was removed in vacuo at 25°C. This vacuum-
3,4,5,6-tetrahydro-2(1H)-pyrimidinone (60 mL) under a dry and inert dried fraction was then dissolved in a minimal volume of CHCl3/CH3OH/
atmosphere and then dry THF (160 mL) was added. The solution was H2O 65:25:4 and further purified on a column of silica gel by using the
cooled to À78°C and a 0.5 M solution of potassium hexamethyldisilazide same solvent system. Fractions were analyzed by TLC, and those fractions
(40 mL, 20 mmol) was added dropwise over a period of 30 min, when a
containing a product with an Rf identical to that of commercially
deep orange colour developed. The reaction mixture was stirred for 1 h available protonated DOPC were combined and the solvent was
at À78°C. Aldehyde 9 (3.0 g, 0.0187 mol) was then added (neat) dropwise removed in vacuo at 25°C. The phospholipid thus obtained (70 mg,
over 30 min. The reaction mixture was stirred at À78°C for 2 h, and then 60%) gave 31P NMR spectra identical to that of the commercially sourced
allowed to come to room temperature over night while stirring. The protonated sample. 1H NMR (400 MHz, CDCl3): δH 0.83 (0.073 H, br m,
reaction was then quenched with water (30 mL) and extracted with residual CH3), 1.23 (1.170 H, br m, residual 10 × CH2), 1.55 (0.046 H, br m,
diethyl ether (4 × 30 mL). The combined organic layers were washed residual CH2), 1.95 (br m, masked by the H2O/OH signal), 2.26 (3.175 H,
sequentially with 0.5 M HCl, saturated NaHCO3 and brine, and dried over br m, residual CH2COO-), 3.37 (9.000 H, s, N(CH3)3), 3.81 (1.946 H, b m,
anhydrous MgSO4. The solvent was evaporated under reduced pressure CH2-CH2-N), 3.96 (1.994 H, m, CH2-CH2-N), 4.12 (1.032H, m, -O-CH2-C(O)
to give a pale yellow oil which was purified on a silica column (eluent: H-CHH-O-P), 4.34 (1.776 H, m, -O-CH2-C(O)H-CH2-O-P), 4.39 (1.090 H, m,
dichloromethane/hexane, 1:1) to give a colourless oil (3.6 g, 60% yield).
-O-CH2-CH-CHH-O-P), 5.21 (0.978H, br m, -O-CH2-C(O)H-CH2-O-P), 5.25
1H NMR (400 MHz, CDCl3): δH 0.82 (0.069 H, br s, residual CH3), 1.23 (0.081 H, b s, residual -CH = CD-) and 5.32 (0.822 H, br s, CH = CD). 2H
(0.337 H, br m, residual 10 × CH2), 1.57 (masked by H2O signal), 1.95 NMR (61.4 MHz, CDCl3): δD 0.81 (3.0D, br s, CD3), 1.20 (17.3D, br s,
(0.139 H, br s, residual 2 × CH2-C = C,), 2.27 (0.873 H, br m, residual 10 × CD2), 1.52 (1.6D, br s, CD2), 1.94 (3.1D, br s, 2 × CD2-C = C), 2.33
CH2COO-), 3.66 (3.000 H, s, O-CH3), 5.25 (0.044 H, br s, residual CH = CD) (0.2D, br m, CD2COO) 5.37 (1.0D, br s, CH = CD). 31P NMR (161.9 MHz,
Copyright © 2013 John Wiley & Sons, Ltd.
J. Label Compd. Radiopharm 2013, 56 520–529